Between 2005 and 2010, research focused on metabolic biomarkers (e.g., homocysteine, C-reactive protein) and pharmaceutical care, reflecting the integration of early mechanistic insights with clinical guidance in diabetes management. Here, CRP is linked to diabetes mellitus.